Weight-Loss Drugs Will Be Blockbusters. Here ’s the Stock to Buy

In the year since Eli Lilly announced trial results showing that tirzepatide—best known by the brand name Mounjaro—helped patients drop more than 20% of their weight, the drug has become the most talked about, and most hyped, pharmaceutical in recent memory. announced trial results showing that…#elililly #mounjaro #lilly #lly #novonordisk #nvo #viagra #novo #bigpharma #johnsonjohnson

Source: Reuters: Health - May 4, 2023 Category: Consumer Health News Source Type: news